Medical dictionary
Medical terminology normalized via MeSH, ICD-11, SNOMED CT.
62,341 terms indexed
A flavoprotein oxidoreductase that has specificity for short-chain fatty acids. It forms a complex with ELECTRON-TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.
An aspect of cholinesterase (EC 3.1.1.8).
A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity.
A plant family of the order Euphorbiales, subclass Rosidae, class Magnoliopsida. Leaves are alternate, simple, and leathery. Fruits are one- or two-seeded capsules or drupes (stony-pitted fleshy fruits).
A plant genus of the family BUXACEAE. Members contain steroidal alkaloids.
a commercial antimicrobial formulation
A condition of BRONCHOCONSTRICTION resulting from hypersensitive reaction to inhaled dust during the initial processing of cotton, flax, or hemp in the textile industry. Symptoms include wheezing and tightness in the chest.
A genus of ascomycetous mold in the family Trichocomaceae, order EUROTIALES. Byssochlamys species are responsible for spoilage and degradation of fruit and fruit juices. Anamorphs are found in the genus PAECILOMYCES.
The result of a positive or negative response (to drugs, for example) in one cell being passed onto other cells via the GAP JUNCTIONS or the intracellular milieu.
An ancient city, the site of modern Istanbul. From the 4th to 15th centuries the empire extended from southeastern Europe to western Asia, reaching its greatest extent under Justinian (527-565). By about 1000 A.D. it comprised the southern Balkans, Greece, Asia Minor, and parts of southern Italy. The capture of Constantinople in 1453 marked the formal end of the Byzantine Empire. (From Webster's New Geographical Dictionary, 1988)
an F-BAR protein; RefSeq NM_001021925
an anti-leishmanial agent; structure in first source
The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin.
A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP).
structure in first source
structure in first source
structure in first source
structure in first source
structure in first source
structure in first source
isolated from Bacillus subtilis; structure in first source
RefSeq NM_022344
synthetic peptide, can interact with CCR4 and attenuate allergic inflammation
RefSeq NM_001031726
RefSeq NM_001014980
RefSeq NM_031908
a tumor-promoting inflammatory regulator; RefSeq NM_031909
RefSeq NM_017860
RefSeq NM_182486
RefSeq NM_026125
synthetic peptide, can interact with CCR4 and attenuate allergic inflammation
RefSeq NM_001017985
copolymer of maleic anhydride, isopropyl maleate, and C30-38 olefin monomers
a synthetic peptide that is the fusion of a FGFR1c-specific monomer and a beta-Klotho specific dimer; an FGF21 agonist
an XIAP (X-llinked inhibitor of apoptosis) inhibitor; structure in first source
RefSeq NM_001168243
structure in first source
a designed 18-mer peptide, consists of three types of amino acids,7 arginine, 7 leucine, and 4 tryptophan residues; structure in first source
RefSeq NM_018325